πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 20 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12410225

Modulation of dendritic cell lineages

Orionis Biosciences, Inc Β· Granted Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12364753

CD8 binding agents

Orionis Biosciences, Inc Β· Granted Tue Jul 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12351614

CLEC9A-based chimeric protein complexes

Orionis Biosciences, Inc Β· Granted Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12351633

PD-1 and PD-L1 binding agents

Orionis Biosciences, Inc Β· Granted Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12091463

Clec9A binding agents comprising a recombinant heavy-chain only antibody (VHH)

Orionis Biosciences, Inc Β· Granted Tue Sep 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12084497

SIRP1Ξ± targeted chimeric proteins and uses thereof

Orionis Biosciences, Inc Β· Granted Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11896643

Fibroblast binding agents and use thereof

Orionis Biosciences, Inc Β· Granted Tue Feb 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11753463

Therapeutic targeting of non-cellular structures

Orionis Biosciences, Inc Β· Granted Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11702477

Bi-functional chimeric proteins and uses thereof

Orionis Biosciences, Inc Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11661455

Chimeric protein comprising an interferon alpha 2mutant and a PD-L1 binding moiety

Orionis Biosciences, Inc Β· Granted Tue May 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11566072

CD8 binding agents

Orionis Biosciences, Inc Β· Granted Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11498966

PD-1 and PD-L1 binding agents

Orionis Biosciences, Inc Β· Granted Tue Nov 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11440943

Therapeutic interferon alpha 1 proteins

Orionis Biosciences, Inc Β· Granted Tue Sep 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11384154

Targeted chimeric proteins and uses thereof

Orionis Biosciences, Inc Β· Granted Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11236166

CD8 binding agents

Orionis Biosciences, Inc Β· Granted Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11236141

Targeted mutant interferon-beta and uses thereof

Orionis Biosciences, Inc Β· Granted Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11084859

Targeted mutant interferon-gamma and uses thereof

Orionis Biosciences, Inc Β· Granted Tue Aug 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11001631

Clec9A binding agents

Orionis Biosciences, Inc Β· Granted Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10988538

Bispecific signaling agents and uses thereof

Orionis Biosciences, Inc Β· Granted Tue Apr 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10906985

Targeted engineered interferon and uses thereof

Orionis Biosciences, Inc Β· Granted Tue Feb 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted